Brought to you by 
Investors bring €40mm to immatics in second round
17 Oct 2013
Executive Summary
New buyers DH Capital and OH Beteiligungen GMBH led a €40mm ($51.96mm) second round financing for cancer company immatics biotechnologies. Other new investors included National Technology Enterprises and KFW Banking, which were joined by existing backers 3i, Wellington Partners, Merifin Capital, Grazia Equity, L-EA/Seed, and EMBL Technology Fund.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Bioinformatics
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Investors bring €40mm to immatics in second round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice